Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells ; volume:13 ; number:1 ; day:8 ; month:12 ; year:2023 ; pages:1-14 ; date:12.2023
Scientific reports ; 13, Heft 1 (8.12.2023), 1-14, 12.2023
- Urheber
-
Lei, Ming
Zhang, Yun-Long
Huang, Feng-Ying
Chen, Heng-Yu
Chen, Ming-Hui
Wu, Ri-Hong
Dai, Shu-Zhen
He, Gui-Sheng
Tan, Guang-Hong
Zheng, Wu-Ping
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-49136-8
- URN
-
urn:nbn:de:101:1-2024022614321953891290
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lei, Ming
- Zhang, Yun-Long
- Huang, Feng-Ying
- Chen, Heng-Yu
- Chen, Ming-Hui
- Wu, Ri-Hong
- Dai, Shu-Zhen
- He, Gui-Sheng
- Tan, Guang-Hong
- Zheng, Wu-Ping
- SpringerLink (Online service)
Ähnliche Objekte (12)
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Coculture with macrophages alters ferroptosis susceptibility of triple-negative cancer cells
DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis
GPX4 restricts ferroptosis of NKp46+ILC3s to control intestinal inflammation
GPX4-independent ferroptosis—a new strategy in disease’s therapy
Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
Enhancing radiotherapy in triple-negative breast cancer with hesperetin-induced ferroptosis via AURKA targeting nanocomposites
Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis
HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells
Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Coculture with macrophages alters ferroptosis susceptibility of triple-negative cancer cells
DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis
GPX4 restricts ferroptosis of NKp46+ILC3s to control intestinal inflammation
GPX4-independent ferroptosis—a new strategy in disease’s therapy
Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
Enhancing radiotherapy in triple-negative breast cancer with hesperetin-induced ferroptosis via AURKA targeting nanocomposites
Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis
HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells
Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Coculture with macrophages alters ferroptosis susceptibility of triple-negative cancer cells
DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis
GPX4 restricts ferroptosis of NKp46+ILC3s to control intestinal inflammation
GPX4-independent ferroptosis—a new strategy in disease’s therapy
Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
Enhancing radiotherapy in triple-negative breast cancer with hesperetin-induced ferroptosis via AURKA targeting nanocomposites
Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis
HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells